Skip to content

Clinical trials

Phase 1/2 Leukemia, Myelomonocytic, Chronic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Phase: Phase 1/2 Country / region: Germany Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20091
20191
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Aptose Biosciences Inc.1
Heinrich-Heine University, Duesseldorf1
Novartis Pharmaceuticals1
Servier Bio-Innovation LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic6
Leukemia, Myeloid, Acute5
Myelodysplastic Syndromes3
Recurrence3
Anemia, Refractory2
Carcinoma, Renal Cell2
Hodgkin Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Non-Hodgkin2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.